IL9R and neoplasm: We sorted lung AMs, CD11c+ and CD11c− IMs from WT Boy/J (CD45.1+) tumor bearing mice and then transferred them to Il9r−/− mice (CD45.2+) 4 days after tumor cell injection (Fig. 5a).